Shanghai Henlius Biotech, Inc. Class H (HK:2696)
:2696
Want to see HK:2696 full AI Analyst Report?
Comparison Results
Shanghai Henlius Biotech, Inc. Class H
HK$84.45
HK$38.67B
―
75.46%
6 Buy
0 Hold
0 Sell
Strong Buy
Zai Lab Ltd
HK$18.27
HK$16.24B
-9.51
-43.39%
7 Buy
0 Hold
0 Sell
Strong Buy
InnoCare Pharma Ltd.
HK$11.75
HK$17.83B
50.10
12.55%
3 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$27.54
HK$39.90B
-256.36
47.70%
3 Buy
0 Hold
0 Sell
Strong Buy
Simcere Pharmaceutical Group Limited
HK$13.79
HK$27.13B
19.91
6.42%
3 Buy
0 Hold
0 Sell
Strong Buy
Ascentage Pharma Group International
HK$50.90
HK$14.37B
-6.78
-12.32%
2 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:2696
Shanghai Henlius Biotech, Inc. Class H
71.15
27.65
63.56%
HK:9688
Zai Lab Ltd
14.35
-10.95
-43.28%
HK:9969
InnoCare Pharma Ltd.
11.93
0.95
8.65%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
23.16
6.22
36.72%
HK:2096
Simcere Pharmaceutical Group Limited
10.45
0.18
1.75%
HK:6855
Ascentage Pharma Group International
38.80
-10.40
-21.14%